Brasada Capital Third Quarter Of 2025 Quarterly Update

Brasada Capital Management analyzes Q3 market resilience, AI-driven capex risks, and selective equity strategies. Explore ...

Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025

Phase 3 study presentations in SLE to show efficacy results across multiple clinical endpoints, including low disease ...
Le Lézard

Cyclic Materials and VACUUMSCHMELZE Expand Partnership to Recycle Rare Earth Magnet Manufacturing Waste in the U.S.

Cyclic Materials, the advanced recycling company creating a circular supply chain for rare earth elements (REEs) and other critical materials, today announced an expansion of its partnership with ...

Market Analysis: Oct 22nd, 2025

The post Market Analysis: Oct 22nd, 2025 appeared first on Stock Target Advisor.
Asia News Network

ASEAN is already economically divided. AI will make it worse

AI adoption in Southeast Asia presents both opportunities and risks, with some nations leading in AI talent while others lag, potentially widening economic disparities.

Microsoft fixes bug preventing classic Outlook launch — but still recommends the new Outlook for Windows as a workaround, despite it not being prime-time ready

The software giant recently indicated that it had fixed an annoying bug preventing users from launching the classic Outlook ...

Kering SA (PPRUY) Q3 2025 Sales Call Transcript

Q3 2025 Sales Call October 22, 2025 12:00 PM EDTCompany ParticipantsArmelle Poulou - Chief Financial OfficerJean-Marc Duplaix ...
Australian Associated Press

Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain

MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 ...